Review: Amyotrophic Lateral Sclerosis Clinical Trials and Interpretation of Functional End Points and Fluid Biomarkers
Jeremy M. Shefner, MD, PhD1; Richard Bedlack, MD, PhD2; Jinsy A. Andrews, MD3; et alJames D. Berry, MD, PhD4; Robert Bowser, PhD1; Robert Brown, MD, DPhil5; Jonathan D. Glass, MD6; Nicholas J. Maragakis, MD7; Timothy M. Miller, MD, PhD8; Jeffrey D. Rothstein, MD, PhD7; Merit E. Cudkowicz, MD4 Author Affiliations Article Information JAMA Neurol. Published online October 17, 2022.